MED
Medifast, Inc.NYSEConsumer Cyclical$10.36+2.57%ClosedMarket Cap: $113.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.57
P/S
0.30
EV/EBITDA
28.44
DCF Value
$63.90
FCF Yield
1.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.3%
Operating Margin
-3.7%
Net Margin
-4.8%
ROE
-8.9%
ROA
-7.3%
ROIC
-6.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $75.1M | 69.4% | $-7.8M | $-18.1M | $-1.65 | — |
| FY 2025 | $385.8M | 71.3% | $-14.2M | $-18.7M | $-1.70 | — |
| Q3 2025 | $89.4M | 69.5% | $-4.1M | $-2.3M | $-0.21 | — |
| Q2 2025 | $105.6M | 72.6% | $-1.1M | $2.5M | $0.22 | — |
| Q1 2025 | $115.7M | 72.8% | $-1.3M | $-772.0K | $-0.07 | — |
| Q4 2024 | $119.0M | 74.1% | $709.0K | $801.0K | $0.07 | — |
| FY 2024 | $602.5M | 73.8% | $2.9M | $2.1M | $0.19 | — |
| Q3 2024 | $140.2M | 75.4% | $2.1M | $1.1M | $0.10 | — |
| Q2 2024 | $168.6M | 73.2% | $-7.9M | $-8.2M | $-0.75 | — |
| Q1 2024 | $174.7M | 72.8% | $7.9M | $8.3M | $0.76 | — |
| Q4 2023 | $191.0M | 74.0% | $8.7M | $6.0M | $0.50 | — |
| FY 2023 | $1.07B | 72.4% | $126.4M | $99.4M | $9.10 | $4.95 |